Primary chemoradiation versus radical hysterectomy with lymphadenectomy for stage IIICr cervical cancer without parametrial involvement: gynecologic oncology research investigators collaboration study (GORILLA-1002)

Read full text Summarise with VIRAT
Authors: Kyung Hee Han, Eunjung Yang, Namkyeong Kim, Joo‐Hyuk Son, Tae‐Wook Kong, Seung‐Hyuk Shim, Dong Hoon Suh, Suk‐Joon Chang, Hee Seung Kim
Cited by: 0
References: 38

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

OBJECTIVE: To compare the effectiveness and adverse events of primary chemoradiation versus radical hysterectomy with pelvic or para-aortic lymphadenectomy in patients with 2018 International Federation of Gynecology and Obstetrics stage IIICr cervical cancer without clinical parametrial involvement. METHODS: This retrospective study included patients diagnosed with stage IIICr cervical cancer who had pelvic or para-aortic lymph nodes measuring at least 1 cm in short diameter on preoperative imaging between 2000 and 2020. Primary chemoradiation consisted of external beam radiation therapy and brachytherapy, while adjuvant chemoradiation following radical surgery was administered based on pathological results. RESULTS: A total of 204 patients underwent primary chemoradiation (n=66) or radical hysterectomy with systematic lymphadenectomy (n=138). There were no significant differences in disease stage or histological type between the groups. In patients with tumors ≥4 cm, primary chemoradiation improved progression-free survival (PFS) compared to radical surgery (5-year survival: 91.1% vs. 61.7%; p

Fields of Study & Subjects

Endometrial and Cervical Cancer Treatments Ovarian cancer diagnosis and treatment Cervical Cancer and HPV Research

Publication details

Journal / source
Journal of Gynecologic Oncology
Volume
37
Issue
5
Pages
e89–e89
Publication date
1 September 2026
Language
EN